2018-10-24 Phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer meets primary endpoint
2018-10-21 Expanded larotrectinib data confirm findings on efficacy and safety in adult and pediatric patients with TRK fusion cancer across various tumor types
2018-10-12 U.S. FDA approves Bayer’s Xarelto® for patients with coronary or peripheral artery disease
